News

Exclusive: US FDA to request Sarepta to stop all shipments of gene therapy Elevidys, source says
The U.S. Food and Drug Administration will request Sarepta Therapeutics to voluntarily stop all shipments of its gene therapy ...
FDA Issues Highest Risk Warning For Dubai Chocolate Recall
The Food and Drug Administration has updated their recall of a batch of Dubai chocolate spread to Class I, their highest ...
FDA Approves Juul E-Cigs for Sale, Years After Ban Attempt
FRIDAY, July 18, 2025 (HealthDay News) — After years of legal battles and health concerns, Juul Labs has the go-ahead to sell ...
FDA makes Juul’s reign official
The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining they’re “appropriate for the ...
FDA Issues Risk Warning for Ice Cream Recalled in 23 States
Rich Ice Cream Co. recalled numerous lots of its products on June 27 over potential contamination with Listeria monocytogenes ...
FDA approves Juul e-cigarette and cartridge sales
Officials with the Food and Drug Administration have approved the continued sales of tobacco-flavored e-cigarettes and refill ...
Juul gets FDA’s OK to keep selling tobacco and menthol e-cigarettes
The Food and Drug Administration is allowing vaping brand Juul to keep its e-cigarettes on the market, providing relief to a ...
FDA approves Juul's tobacco and menthol e-cigarettes
The U.S. Food and Drug Administration has authorized the sale of Juul Labs' e-cigarette device and refill cartridges in ...
FDA Plans to Revoke 52 Food Standards
The 52 food standards pertain to canned fruits and vegetables, dairy products, baked goods, macaroni products, and other ...
F.D.A. Panelists Call for Removal of Warnings on Menopause Treatments
Dr. Marty Makary, the agency’s commissioner, said too many women avoid hormone therapy because the risks have been overstated ...
F.D.A. Approves Juul Vapes After Yearslong Delay
The Food and Drug Administration authorized Juul e-cigarettes for the U.S. market on Thursday, ending a lengthy standoff with ...
GSK's blood cancer drug fails to secure US FDA advisers' support
The U.S. FDA's panel of independent advisers on Thursday recommended against GSK's blood cancer drug Blenrep, citing concerns ...